Overview

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the effect of raltegravir on pravastatin pharmacokinetics and vice versa by intrasubject comparison.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Pravastatin
Raltegravir Potassium